Eri Matsuki

694 total citations
41 papers, 492 citations indexed

About

Eri Matsuki is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Eri Matsuki has authored 41 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 17 papers in Genetics and 9 papers in Oncology. Recurrent topics in Eri Matsuki's work include Chronic Myeloid Leukemia Treatments (14 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Eosinophilic Disorders and Syndromes (9 papers). Eri Matsuki is often cited by papers focused on Chronic Myeloid Leukemia Treatments (14 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Eosinophilic Disorders and Syndromes (9 papers). Eri Matsuki collaborates with scholars based in Japan, United States and United Kingdom. Eri Matsuki's co-authors include Anas Younes, Connie Lee Batlevi, Renier J. Brentjens, Shinichiro Okamoto, Kenji Yokoyama, Takayuki Shimizu, Masatoshi Sakurai, Yoshitaka Miyakawa, Daiki Karigane and Yuiko Tsukada and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Eri Matsuki

39 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eri Matsuki Japan 11 249 153 134 132 127 41 492
Laure Farnault France 11 185 0.7× 135 0.9× 51 0.4× 121 0.9× 86 0.7× 38 549
Tadahiko Igarashi Japan 14 296 1.2× 143 0.9× 107 0.8× 59 0.4× 127 1.0× 45 577
Lu Yu China 16 383 1.5× 131 0.9× 38 0.3× 58 0.4× 90 0.7× 48 685
Isabelle Genvresse Germany 12 157 0.6× 169 1.1× 104 0.8× 76 0.6× 99 0.8× 27 472
Marcin Pasiarski Poland 11 194 0.8× 93 0.6× 95 0.7× 170 1.3× 86 0.7× 33 413
Bhausaheb Bagal India 10 146 0.6× 142 0.9× 101 0.8× 92 0.7× 107 0.8× 104 413
Shilpa Paul United States 13 232 0.9× 294 1.9× 52 0.4× 50 0.4× 180 1.4× 41 670
Plamen Kossev United States 9 238 1.0× 122 0.8× 165 1.2× 101 0.8× 101 0.8× 13 611
Leopold Öhler Austria 13 200 0.8× 198 1.3× 35 0.3× 77 0.6× 106 0.8× 49 478
Q.H. Le France 8 170 0.7× 313 2.0× 81 0.6× 34 0.3× 163 1.3× 16 613

Countries citing papers authored by Eri Matsuki

Since Specialization
Citations

This map shows the geographic impact of Eri Matsuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eri Matsuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eri Matsuki more than expected).

Fields of papers citing papers by Eri Matsuki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eri Matsuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eri Matsuki. The network helps show where Eri Matsuki may publish in the future.

Co-authorship network of co-authors of Eri Matsuki

This figure shows the co-authorship network connecting the top 25 collaborators of Eri Matsuki. A scholar is included among the top collaborators of Eri Matsuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eri Matsuki. Eri Matsuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sugimoto, Miki, Kaori Yagasaki, Eri Matsuki, et al.. (2025). Unmet Needs and Health‐Related Quality of Life Among Patients With Relapsed/Refractory Indolent Non‐Hodgkin Lymphoma: A Mixed‐Methods Study. Psycho-Oncology. 34(2). e70103–e70103.
2.
Sakurai, Masatoshi, Yuya Koda, Eri Matsuki, et al.. (2025). Lymphoma risk in autoimmune diseases with multiple medication use: analysis from the LIFE Study. Blood Cancer Journal. 16(1). 11–11.
3.
Kondo, Takeshi, Eri Matsuki, Tomoiku Takaku, et al.. (2024). Outcomes of pregnancy in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitors. Cancer. 131(1). e35611–e35611. 1 indexed citations
4.
Matsuki, Eri, et al.. (2023). The Impact of Cold Ambient Temperature in the Pattern of Influenza Virus Infection. Open Forum Infectious Diseases. 10(2). ofad039–ofad039. 5 indexed citations
5.
Miyata, Masahiro, Kazunobu Ichikawa, Eri Matsuki, et al.. (2022). Recent Advances of Acute Kidney Injury in Hematopoietic Cell Transplantation. Frontiers in Immunology. 12. 779881–779881. 15 indexed citations
6.
Peltier, Daniel, et al.. (2022). How does transfusion-associated graft-versus-host disease compare to hematopoietic cell transplantation-associated graft-versus-host disease?. Transfusion and Apheresis Science. 61(2). 103405–103405. 3 indexed citations
7.
Masaki, Katsunori, Shigeharu Ueki, Keiji Tanese, et al.. (2021). Eosinophilic annular erythema showing eosinophil cytolytic ETosis successfully treated with benralizumab. Asia Pacific Allergy. 11(3). e28–e28. 6 indexed citations
8.
Suzuki, Natsuko, Eri Matsuki, Sayumi Watanabe, et al.. (2020). Association among chronic kidney disease, airflow limitation, and mortality in a community-based population: The Yamagata (Takahata) study. Scientific Reports. 10(1). 5570–5570. 6 indexed citations
9.
Sakurai, Masatoshi, Taku Kikuchi, Daiki Karigane, et al.. (2019). Renal dysfunction and anemia associated with long-term imatinib treatment in patients with chronic myelogenous leukemia. International Journal of Hematology. 109(3). 292–298. 17 indexed citations
10.
Matsushita, Maiko, Kyoko Ozawa, Takaya Suzuki, et al.. (2017). CXorf48 is a potential therapeutic target for achieving treatment-free remission in CML patients. Blood Cancer Journal. 7(9). e601–e601. 12 indexed citations
11.
Batlevi, Connie Lee, Eri Matsuki, Renier J. Brentjens, & Anas Younes. (2015). Novel immunotherapies in lymphoid malignancies. Nature Reviews Clinical Oncology. 13(1). 25–40. 184 indexed citations
12.
Matsuki, Eri & Anas Younes. (2015). Lymphomagenesis in Hodgkin lymphoma. Seminars in Cancer Biology. 34. 14–21. 26 indexed citations
13.
14.
Kumagai, Takashi, Eri Matsuki, Koiti Inokuchi, et al.. (2013). Relative increase in lymphocytes from as early as 1 month predicts improved response to dasatinib in chronic-phase chronic myelogenous leukemia. International Journal of Hematology. 99(1). 41–52. 19 indexed citations
15.
Yokoyama, Kenji, Shinichiro Okamoto, Keiko Asakura, et al.. (2012). Post-transplant consolidation therapy using thalidomide alone for the patients with multiple myeloma: a feasibility study in Japanese population. International Journal of Hematology. 96(4). 477–484. 1 indexed citations
16.
Kikuchi, Kentaro, Harumi Inoue, Yuji Miyazaki, et al.. (2012). Adult Sporadic Burkitt Lymphoma of the Oral Cavity: A Case Report and Literature Review. Journal of Oral and Maxillofacial Surgery. 70(12). 2936–2943. 12 indexed citations
17.
18.
Matsuki, Eri, Yoshitaka Miyakawa, Shuichi Asakawa, et al.. (2011). Identification of Loss of p16 Expression and Upregulation of MDR-1 as Genetic Events Resulting from Two Novel Chromosomal Translocations Found in a Plasmablastic Lymphoma of the Uterus. Clinical Cancer Research. 17(8). 2101–2109. 10 indexed citations
19.
Matsuki, Eri, Yoshitaka Miyakawa, Akiko Yamane, & Shinichiro Okamoto. (2011). Humanized VB22B minibody for human Mpl stimulates human megakaryopoiesis but does not enhance platelet aggregation. Experimental Hematology. 39(8). 829–836. 2 indexed citations
20.
Matsuki, Eri, Yoshitaka Miyakawa, & Shinichiro Okamoto. (2011). A novel factor XII mutation, FXII R84P, causing factor XII deficiency in a patient with hereditary spastic paraplegia. Blood Coagulation & Fibrinolysis. 22(3). 227–230. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laure Farnault Breakdown of academic impact, for papers by Tadahiko Igarashi Breakdown of academic impact, for papers by Lu Yu Breakdown of academic impact, for papers by Isabelle Genvresse Breakdown of academic impact, for papers by Marcin Pasiarski Breakdown of academic impact, for papers by Bhausaheb Bagal Breakdown of academic impact, for papers by Shilpa Paul Breakdown of academic impact, for papers by Plamen Kossev Breakdown of academic impact, for papers by Leopold Öhler Breakdown of academic impact, for papers by Q.H. Le
Rankless by CCL
2026